Skip to main content

Correction: Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients

The Original Article was published on 07 September 2022

Correction: BMC Nephrol 23, 306 (2022)

https://doi.org/10.1186/s12882-022-02914-4

Following publication of the original article [1], the authors informed us that the first “Excluded” box in Fig. 1 is incomplete. The correct Fig. 1 is given below.

Fig. 1
figure 1

Inclusion flowchart of patients with idiopathic membranous nephropathy

The original article has been corrected.

Reference

  1. Wang, et al. Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients. BMC Nephrol. 2022;23:306. https://doi.org/10.1186/s12882-022-02914-4.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xin Wei.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, B., Zhu, Z., Huang, F. et al. Correction: Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients. BMC Nephrol 23, 321 (2022). https://doi.org/10.1186/s12882-022-02950-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12882-022-02950-0